The presence of iMSCs was confirmed by in situ immunofluorescence staining for IL-1R1 in FFPE BM tissue, revealing higher IL-1R1+ cell counts in MDS compared to Control and CHIP donors (Fig. 3F, G). This evidence concerns the gene STUB1 and myelodysplastic syndrome.